{"id":"https://openalex.org/W4323657828","doi":"https://doi.org/10.1016/j.jclinepi.2023.03.006","title":"Early phase clinical trial played a critical role in the Food and Drug Administration\u2013approved indications for targeted anticancer drugs: a cross-sectional study from 2012 to 2021","display_name":"Early phase clinical trial played a critical role in the Food and Drug Administration\u2013approved indications for targeted anticancer drugs: a cross-sectional study from 2012 to 2021","alternate_titles":[],"publication_year":2023,"publication_date":"2023-03-10","ids":{"openalex":"https://openalex.org/W4323657828","doi":"https://doi.org/10.1016/j.jclinepi.2023.03.006","pmid":"https://pubmed.ncbi.nlm.nih.gov/36905971"},"language":"en","primary_location":{"id":"doi:10.1016/j.jclinepi.2023.03.006","doi":"https://doi.org/10.1016/j.jclinepi.2023.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jclinepi.2023.03.006","pdf_url":"http://www.jclinepi.com/article/S0895435623000495/pdf","source":{"id":"https://openalex.org/S64418186","display_name":"Journal of Clinical Epidemiology","issn_l":"0895-4356","issn":["0895-4356","1878-5921"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Epidemiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4323657828"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.jclinepi.com/article/S0895435623000495/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101553491","display_name":"Yafang Huang","orcid":"https://orcid.org/0000-0003-4396-3870","observed_orcids":["https://orcid.org/0000-0003-4396-3870"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yafang Huang","raw_affiliation_strings":["School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: yafang@ccmu.edu.cn","School of General Practice and Continuing Education, Capital Medical University, Beijing, China"],"raw_orcid":"https://orcid.org/0000-0003-4396-3870","affiliations":[{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: yafang@ccmu.edu.cn","institution_ids":["https://openalex.org/I183519381"]},{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009664665","display_name":"Weiyi Xiong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weiyi Xiong","raw_affiliation_strings":["Department II of Pharmaceuticals Surveillance and Evaluation, National Center for ADR monitoring, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department II of Pharmaceuticals Surveillance and Evaluation, National Center for ADR monitoring, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jingwei Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingwei Zhao","raw_affiliation_strings":["School of General Practice and Continuing Education, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100451414","display_name":"Wentao Li","orcid":"https://orcid.org/0000-0002-8400-3326","observed_orcids":["https://orcid.org/0000-0002-8400-3326"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wentao Li","raw_affiliation_strings":["School of General Practice and Continuing Education, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054418300","display_name":"Li Ma","orcid":"https://orcid.org/0000-0003-0894-7867","observed_orcids":["https://orcid.org/0000-0003-0894-7867"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210087691","display_name":"Beijing Tian Tan Hospital","ror":"https://ror.org/003regz62","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210087691"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Ma","raw_affiliation_strings":["Department of General Practice, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Practice, Beijing Tiantan Hospital, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210087691"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042991739","display_name":"Hao Wu","orcid":"https://orcid.org/0000-0002-8903-4658","observed_orcids":["https://orcid.org/0000-0002-8903-4658"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Hao Wu","raw_affiliation_strings":["School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: wushunzhe@ccmu.edu.cn","School of General Practice and Continuing Education, Capital Medical University, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: wushunzhe@ccmu.edu.cn","institution_ids":["https://openalex.org/I183519381"]},{"raw_affiliation_string":"School of General Practice and Continuing Education, Capital Medical University, Beijing, China","institution_ids":["https://openalex.org/I183519381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5042991739","https://openalex.org/A5101553491"],"corresponding_institution_ids":["https://openalex.org/I183519381"],"apc_list":{"value":3870,"currency":"USD","value_usd":3870},"apc_paid":{"value":3870,"currency":"USD","value_usd":3870},"fwci":1.7211,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.87123963,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"157","issue":null,"first_page":"74","last_page":"82"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8041999936103821,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.06310000270605087,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.05180000141263008,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-anticancer-drugs","display_name":"targeted anticancer drugs","score":0.9150000214576721},{"id":"https://openalex.org/keywords/fda-drug-approval","display_name":"FDA drug approval","score":0.8240000009536743},{"id":"https://openalex.org/keywords/accelerated-approval","display_name":"accelerated approval","score":0.7160000205039978},{"id":"https://openalex.org/keywords/regulatory-evidence","display_name":"regulatory evidence","score":0.3630000054836273},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9115814566612244},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7662991285324097},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.6050494909286499},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5468567609786987},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4839535057544708},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.46023181080818176},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4519224166870117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4299297332763672},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4123242497444153},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36664313077926636}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jclinepi.2023.03.006","doi":"https://doi.org/10.1016/j.jclinepi.2023.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jclinepi.2023.03.006","pdf_url":"http://www.jclinepi.com/article/S0895435623000495/pdf","source":{"id":"https://openalex.org/S64418186","display_name":"Journal of Clinical Epidemiology","issn_l":"0895-4356","issn":["0895-4356","1878-5921"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Epidemiology","raw_type":"journal-article"},{"id":"pmid:36905971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36905971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical epidemiology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1016/j.jclinepi.2023.03.006","doi":"https://doi.org/10.1016/j.jclinepi.2023.03.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jclinepi.2023.03.006","pdf_url":"http://www.jclinepi.com/article/S0895435623000495/pdf","source":{"id":"https://openalex.org/S64418186","display_name":"Journal of Clinical Epidemiology","issn_l":"0895-4356","issn":["0895-4356","1878-5921"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Epidemiology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2771496517","display_name":null,"funder_award_id":"82104133","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G4963875777","display_name":null,"funder_award_id":"2022-1-005","funder_id":"https://openalex.org/F4320323114","funder_display_name":"Beijing Municipal Health Commission"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320323114","display_name":"Beijing Municipal Health Commission","ror":"https://ror.org/0374a5s68"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4323657828.pdf","grobid_xml":"https://content.openalex.org/works/W4323657828.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1239915614","https://openalex.org/W1810662963","https://openalex.org/W1974897855","https://openalex.org/W1990675339","https://openalex.org/W2029122528","https://openalex.org/W2109314733","https://openalex.org/W2154008785","https://openalex.org/W2166380979","https://openalex.org/W2171242595","https://openalex.org/W2235654639","https://openalex.org/W2286954003","https://openalex.org/W2291203170","https://openalex.org/W2528770524","https://openalex.org/W2547330766","https://openalex.org/W2588055238","https://openalex.org/W2746717271","https://openalex.org/W2754725540","https://openalex.org/W2778174446","https://openalex.org/W2793539832","https://openalex.org/W2803744378","https://openalex.org/W2810896552","https://openalex.org/W2810960090","https://openalex.org/W2818300374","https://openalex.org/W2913586476","https://openalex.org/W2952798589","https://openalex.org/W2998984898","https://openalex.org/W3035947584","https://openalex.org/W3063106878","https://openalex.org/W3081278682","https://openalex.org/W3121915712","https://openalex.org/W3125367466","https://openalex.org/W3159844184","https://openalex.org/W3172213464","https://openalex.org/W3189949217","https://openalex.org/W3191219220","https://openalex.org/W3206796634","https://openalex.org/W3213050308","https://openalex.org/W4200461303","https://openalex.org/W4210880568","https://openalex.org/W4211238337","https://openalex.org/W4286490560"],"related_works":["https://openalex.org/W4412831626","https://openalex.org/W4226403841","https://openalex.org/W2505192176","https://openalex.org/W3043204261","https://openalex.org/W2970968610","https://openalex.org/W2173701885","https://openalex.org/W2605062205","https://openalex.org/W3004332746","https://openalex.org/W2284126035","https://openalex.org/W4400583067"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"characterize":[2],"the":[3,7,15,39,67,78,123,131,135,151,184],"indications":[4,64,74,120,132],"approved":[5,48,65,76,121,133],"by":[6,66],"US":[8],"Food":[9],"and":[10,23,52,71,99,114,147,163],"Drug":[11],"Administration":[12],"(FDA)":[13],"on":[14,77,122,134],"basis":[16,79,124,136],"of":[17,27,44,80,86,112,125,137,153,156,187],"early":[18],"phase":[19,28,104,126,165],"clinical":[20],"trials":[21,98,162,167],"(EPCTs)":[22],"compared":[24],"with":[25,62,82,108,119],"that":[26],"three":[29,127],"randomized":[30,128],"controlled":[31,129],"trials.":[32,158],"STUDY":[33],"DESIGN":[34],"AND":[35],"SETTING:":[36],"We":[37,56],"collected":[38],"publicly":[40],"available":[41],"FDA":[42,185],"documents":[43],"targeted":[45,59,188],"anticancer":[46,60,189],"drugs":[47,61],"between":[49],"January":[50],"2012":[51],"December":[53],"2021.":[54],"RESULTS:":[55],"identified":[57],"95":[58],"188":[63],"FDA.":[68],"One":[69],"hundred":[70],"twelve":[72],"(59.6%)":[73],"were":[75,95,102],"EPCTs,":[81,92],"a":[83,109,169,176],"significant":[84,110],"increase":[85,111],"22.2%":[87],"per":[88,116],"year.":[89,117],"Of":[90],"112":[91],"32":[93],"(28.6%)":[94],"dose-expansion":[96],"cohort":[97,161],"75":[100],"(67.0%)":[101],"single-arm":[103,164],"2":[105,166],"trials,":[106,130],"respectively,":[107],"29.7%":[113],"18.7%":[115],"Compared":[118],"EPCTs":[138],"had":[139],"significantly":[140],"higher":[141],"odds":[142,149],"in":[143,150,172,180],"receiving":[144],"accelerated":[145],"approval":[146],"lower":[148],"number":[152],"entered":[154],"patients":[155],"pivotal":[157],"CONCLUSIONS:":[159],"Dose-expansion":[160],"played":[168],"critical":[170],"role":[171],"EPCTs.":[173],"EPCT":[174],"was":[175],"major":[177],"trial":[178],"type":[179],"providing":[181],"evidences":[182],"for":[183],"approvals":[186],"drugs.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4323657828","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-03-10T00:00:00"}
